| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.06 |